| Hans-Günter Meyer-Thompson | Ukraine
End of treatment and 12-month post-treatment outcomes in patients treated with all-oral regimens for rifampicin-resistant tuberculosis in Ukraine: a prospective cohort study.
End of treatment and 12-month post-treatment outcomes in patients treated with all-oral regimens for rifampicin-resistant tuberculosis in Ukraine: a prospective cohort study.
Fardhdiani V, Trush O, Lytvynenko N, Pylypchuk S, Terleeva Y, Malakyan K, Rupasinghe P, Wally Y, Duka M, Didyk VS, Siomak OV, Blyzniuk O, Furin J, Donchuk D, Laxmeshwar C, Isaakidis P.
PLOS Glob Public Health. 2025 May 23;5(5):e0003983. doi: 10.1371/journal.pgph.0003983. PMID: 40408534; PMCID: PMC12101767.